Approval · Notice of Compliance 813 · 2002
URSO DS: Notice of Compliance 813
Issued September 9, 2002
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 813
- Date
- September 9, 2002
- Company
- Axcan Pharma Inc.Mont St-Hilaire, Quebec, Canada
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to a New Drug Submission (SNDS), supplement
- Submission class
- Admin
- Reason
- Product name change
- Therapeutic class
- Cholestatic liver diseases
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| URSO DS | 02245894 | Cancelled Post Market |
Medicinal ingredients
- URSODIOL 500 MG per TAB